{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:51:32Z","timestamp":1788288692238,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ucl.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T02:32:50Z","timestamp":1710124370000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sleep and Overactive Bladder in Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"51","author":[{"given":"Yu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne P.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9996","key":"10.1016\/j.ucl.2024.02.005_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet Lond Engl"},{"issue":"11","key":"10.1016\/j.ucl.2024.02.005_bib2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/mds.21586","article-title":"Prevalence of nonmotor symptoms in Parkinson\u2019s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients","volume":"22","author":"Martinez-Martin","year":"2007","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"2B","key":"10.1016\/j.ucl.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0004-282X2003000300007","article-title":"Urinary symptoms in Parkinson\u2019s disease: prevalence and associated factors","volume":"61","author":"Campos-Sousa","year":"2003","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.ucl.2024.02.005_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.995850","article-title":"Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"14","author":"Li","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"10.1016\/j.ucl.2024.02.005_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/nau.23917","article-title":"International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function","volume":"38","author":"Hashim","year":"2019","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"10.1016\/j.ucl.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/nau.22365","article-title":"Nocturia and overnight polysomnography in Parkinson disease","volume":"32","author":"Vaughan","year":"2013","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"10.1016\/j.ucl.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/jpm13071053","article-title":"Nocturia and Sleep in Parkinson\u2019s Disease","volume":"13","author":"Diaconu","year":"2023","journal-title":"J\u00a0Personalized Med"},{"issue":"7","key":"10.1016\/j.ucl.2024.02.005_bib8","first-page":"2029","article-title":"Management of Sleep Disturbances in Parkinson\u2019s Disease","volume":"12","author":"Sch\u00fctz","year":"2022","journal-title":"J\u00a0Park Dis"},{"issue":"3","key":"10.1016\/j.ucl.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ucl.2017.04.008","article-title":"Parkinson\u2019s Disease and Its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies","volume":"44","author":"Brucker","year":"2017","journal-title":"Urol Clin North Am"},{"issue":"12","key":"10.1016\/j.ucl.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/jnnp.2011.241075","article-title":"Urinary dysfunction in early and untreated Parkinson\u2019s disease","volume":"82","author":"Uchiyama","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ucl.2024.02.005_bib11","first-page":"1640","article-title":"Voiding dysfunction and Parkinson\u2019s disease: urodynamic abnormalities and urinary symptoms","volume":"164","author":"Araki","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2024.02.005_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neulet.2010.02.015","article-title":"Neuronal activities of forebrain structures with respect to bladder contraction in cats","volume":"473","author":"Yamamoto","year":"2010","journal-title":"Neurosci Lett"},{"issue":"Pt 12","key":"10.1016\/j.ucl.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1093\/brain\/awl302","article-title":"Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson\u2019s disease","volume":"129","author":"Herzog","year":"2006","journal-title":"Brain J Neurol"},{"issue":"10","key":"10.1016\/j.ucl.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41593-023-01398-1","article-title":"Prefrontal cortical regulation of REM sleep","volume":"26","author":"Hong","year":"2023","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.ucl.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12883-021-02153-4","article-title":"Evaluation of neurogenic bladder outlet obstruction mimicking sphincter bradykinesia in male patients with Parkinson\u2019s disease","volume":"21","author":"Xing","year":"2021","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.ucl.2024.02.005_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11906-022-01168-7","article-title":"Advances in the\u00a0Pathophysiology and Management of Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension","volume":"24","author":"Park","year":"2022","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1016\/j.ucl.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","article-title":"Orthostatic Hypotension in Parkinson Disease","volume":"36","author":"Palma","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"10.1016\/j.ucl.2024.02.005_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ucl.2024.02.005_bib19","doi-asserted-by":"crossref","first-page":"101281","DOI":"10.1016\/j.smrv.2020.101281","article-title":"Sleep in Parkinson\u2019s disease: A systematic review and meta-analysis of polysomnographic findings","volume":"51","author":"Zhang","year":"2020","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.ucl.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fneur.2017.00042","article-title":"The Treatment of Sleep Disorders in Parkinson\u2019s Disease: From Research to Clinical Practice","volume":"8","author":"Loddo","year":"2017","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.ucl.2024.02.005_bib21","doi-asserted-by":"crossref","first-page":"zsx101","DOI":"10.1093\/sleep\/zsx101","article-title":"REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson\u2019s Disease","volume":"40","author":"Jozwiak","year":"2017","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.ucl.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1212\/WNL.59.4.585","article-title":"REM sleep behavior disorder and REM sleep without atonia in Parkinson\u2019s disease","volume":"59","author":"Gagnon","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ucl.2024.02.005_bib23","doi-asserted-by":"crossref","first-page":"101759","DOI":"10.1016\/j.smrv.2023.101759","article-title":"Sleep and wakefulness disturbances in Parkinson\u2019s disease: A meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia","volume":"68","author":"Maggi","year":"2023","journal-title":"Sleep Med Rev"},{"issue":"5","key":"10.1016\/j.ucl.2024.02.005_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/mdc3.12374","article-title":"Nocturia in Parkinson\u2019s Disease: Why Does It Occur and How to Manage?","volume":"3","author":"Batla","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"10.1016\/j.ucl.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2009.03.080","article-title":"Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland","volume":"57","author":"Tikkinen","year":"2010","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.ucl.2024.02.005_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1179\/1743132815Y.0000000010","article-title":"Association between nocturia and anxiety in Parkinson\u2019s disease","volume":"37","author":"Rana","year":"2015","journal-title":"Neurol Res"},{"issue":"3","key":"10.1016\/j.ucl.2024.02.005_bib27","first-page":"953","article-title":"The association of depression, anxiety and nocturia: a systematic review","volume":"190","author":"Breyer","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2024.02.005_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5114\/ninp.2013.38222","article-title":"Causes and consequences of falls in Parkinson disease patients in a prospective study","volume":"47","author":"Rudzi\u0144ska","year":"2013","journal-title":"Neurol Neurochir Pol"},{"issue":"8","key":"10.1016\/j.ucl.2024.02.005_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/nau.20712","article-title":"Nocturia is an age-independent risk factor for hip-fractures in men","volume":"28","author":"Temml","year":"2009","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 1","key":"10.1016\/j.ucl.2024.02.005_bib30","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.21037\/apm.2019.10.01","article-title":"Patient and caregiver characteristics associated with caregiver burden in Parkinson\u2019s disease: a palliative care approach","volume":"9","author":"Macchi","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"8","key":"10.1016\/j.ucl.2024.02.005_bib31","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/nau.24113","article-title":"Are three-day voiding diaries feasible and reliable? Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) cohort","volume":"38","author":"Cameron","year":"2019","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"10.1016\/j.ucl.2024.02.005_bib32","first-page":"1097","article-title":"The AUA\/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation","volume":"206","author":"Ginsberg","year":"2021","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2024.02.005_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.parkreldis.2014.12.003","article-title":"Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson\u2019s disease","volume":"21","author":"Kim","year":"2015","journal-title":"Parkinsonism Relat Disorders"},{"issue":"1","key":"10.1016\/j.ucl.2024.02.005_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1464-410X.2008.07463.x","article-title":"How should patients with an overactive bladder manipulate their fluid intake?","volume":"102","author":"Hashim","year":"2008","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2024.02.005_bib35","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/nau.24052","article-title":"Behavioral therapy for urinary symptoms in Parkinson\u2019s disease: A randomized clinical trial","volume":"38","author":"Vaughan","year":"2019","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.ucl.2024.02.005_bib36","first-page":"11216","article-title":"Patient and caretaker satisfaction with the PureWick system","volume":"29","author":"Khosla","year":"2022","journal-title":"Can J Urol"},{"issue":"s1","key":"10.1016\/j.ucl.2024.02.005_bib37","first-page":"S57","article-title":"Management of Orthostatic Hypotension in Parkinson\u2019s Disease","volume":"10","author":"Fanciulli","year":"2020","journal-title":"J\u00a0Park Dis"},{"issue":"4","key":"10.1016\/j.ucl.2024.02.005_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11845-008-0233-0","article-title":"Physiological effects of sleeping with the head of the bed elevated 18 in. in young healthy volunteers","volume":"177","author":"Fan","year":"2008","journal-title":"Ir J Med Sci"},{"issue":"1","key":"10.1016\/j.ucl.2024.02.005_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1468-1331.2011.03442.x","article-title":"Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson\u2019s disease","volume":"19","author":"Ray Chaudhuri","year":"2012","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.ucl.2024.02.005_bib40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson\u2019s disease: a double-blind, double-dummy, randomised controlled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ucl.2024.02.005_bib41","first-page":"3724148","article-title":"Rotigotine Objectively Improves Sleep in Parkinson\u2019s Disease: An Open-Label Pilot Study with Actigraphic Recording","volume":"2016","author":"Calandra-Buonaura","year":"2016","journal-title":"Park Dis"},{"key":"10.1016\/j.ucl.2024.02.005_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.smrv.2016.08.001","article-title":"A\u00a0systematic review of the literature on disorders of sleep and wakefulness in Parkinson\u2019s disease from 2005 to 2015","volume":"35","author":"Chahine","year":"2017","journal-title":"Sleep Med Rev"},{"issue":"4","key":"10.1016\/j.ucl.2024.02.005_bib43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1468-1331.2010.03213.x","article-title":"Effect of controlled-release levodopa on the microstructure of sleep in Parkinson\u2019s disease","volume":"18","author":"Wailke","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ucl.2024.02.005_bib44","doi-asserted-by":"crossref","first-page":"116625","DOI":"10.1016\/j.jns.2019.116625","article-title":"Extended release levodopa at bedtime as a treatment for nocturiain Parkinson\u2019s disease: An open label study","volume":"410","author":"Brusa","year":"2020","journal-title":"J\u00a0Neurol Sci"},{"issue":"6","key":"10.1016\/j.ucl.2024.02.005_bib45","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/ene.14774","article-title":"Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson\u2019s disease","volume":"28","author":"Batla","year":"2021","journal-title":"Eur J Neurol"},{"issue":"18","key":"10.1016\/j.ucl.2024.02.005_bib46","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1212\/01.wnl.0000260605.12506.86","article-title":"Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease","volume":"68","author":"Brusa","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ucl.2024.02.005_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.parkreldis.2003.08.001","article-title":"Effects of pergolide on nocturia in Parkinson\u2019s disease: three female cases selected from over 400 patients","volume":"10","author":"Kuno","year":"2004","journal-title":"Parkinsonism Relat Disorders"},{"issue":"3","key":"10.1016\/j.ucl.2024.02.005_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/nau.1930120302","article-title":"Effects of apomorphine and L-dopa on the parkinsonian bladder","volume":"12","author":"Aranda","year":"1993","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"10.1016\/j.ucl.2024.02.005_bib49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.parkreldis.2014.04.020","article-title":"Rasagiline effect on bladder disturbances in early mild Parkinson\u2019s disease patients","volume":"20","author":"Brusa","year":"2014","journal-title":"Parkinsonism Relat Disorders"},{"issue":"2","key":"10.1016\/j.ucl.2024.02.005_bib50","first-page":"e46","article-title":"Does deep brain stimulation improve Parkinson\u2019s disease-related lower urinary tract symptoms and voiding dysfunction?","volume":"8","author":"Tabakin","year":"2021","journal-title":"Bladder San Franc Calif"},{"issue":"8","key":"10.1016\/j.ucl.2024.02.005_bib51","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/nau.22237","article-title":"Bladder dysfunction in advanced Parkinson\u2019s disease","volume":"31","author":"Winge","year":"2012","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.ucl.2024.02.005_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ana.10806","article-title":"Effect of subthalamic deep brain stimulation on the function of the urinary bladder","volume":"55","author":"Seif","year":"2004","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ucl.2024.02.005_bib53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/nau.23301","article-title":"Does deep brain stimulation improve lower urinary tract symptoms in Parkinson\u2019s disease?","volume":"37","author":"Witte","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ucl.2024.02.005_bib54","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2147\/CIA.S204368","article-title":"Clinical study of the effects of deep brain stimulation on urinary dysfunctions in patients with Parkinson\u2019s disease","volume":"14","author":"Zong","year":"2019","journal-title":"Clin Interv Aging"},{"issue":"2 Pt 1","key":"10.1016\/j.ucl.2024.02.005_bib55","first-page":"749","article-title":"Can higher doses of oxybutynin improve efficacy in neurogenic bladder?","volume":"171","author":"Bennett","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.ucl.2024.02.005_bib56","first-page":"931","article-title":"Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and\/or low-compliance bladder","volume":"17","author":"Watanabe","year":"2010","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"issue":"4","key":"10.1016\/j.ucl.2024.02.005_bib57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.WNF.0000228177.75711.0f","article-title":"Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment","volume":"29","author":"Palleschi","year":"2006","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"10.1016\/j.ucl.2024.02.005_bib58","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson\u2019s disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkinsonism Relat Disorders"},{"issue":"8","key":"10.1016\/j.ucl.2024.02.005_bib59","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00345-019-02981-7","article-title":"Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson\u2019s disease","volume":"38","author":"Yonguc","year":"2020","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2024.02.005_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2022.01.045","article-title":"European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence","volume":"82","author":"Nambiar","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2024.02.005_bib61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2018.07.005","article-title":"Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort","volume":"57","author":"Peyronnet","year":"2018","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.ucl.2024.02.005_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419843458","article-title":"Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson\u2019s disease: A pilot study","volume":"12","author":"Gubbiotti","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"10.1016\/j.ucl.2024.02.005_bib63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.870100318","article-title":"Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson\u2019s disease","volume":"10","author":"Suchowersky","year":"1995","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"8","key":"10.1016\/j.ucl.2024.02.005_bib64","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/nau.23717","article-title":"Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson\u2019s disease","volume":"37","author":"Vurture","year":"2018","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.ucl.2024.02.005_bib65","first-page":"1453","article-title":"Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson\u2019s disease and multiple system atrophy","volume":"182","author":"Giannantoni","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.ucl.2024.02.005_bib66","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.parkreldis.2010.06.006","article-title":"Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons\u2019s disease","volume":"16","author":"Kulaksizoglu","year":"2010","journal-title":"Parkinsonism Relat Disorders"},{"issue":"1","key":"10.1016\/j.ucl.2024.02.005_bib67","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12894-016-0174-2","article-title":"Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson\u2019s disease","volume":"16","author":"Kn\u00fcpfer","year":"2016","journal-title":"BMC Urol"},{"key":"10.1016\/j.ucl.2024.02.005_bib68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.urology.2015.09.026","article-title":"The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson\u2019s Disease","volume":"87","author":"Kabay","year":"2016","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2024.02.005_bib69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/nau.20593","article-title":"Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson\u2019s disease","volume":"28","author":"Kabay","year":"2009","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"10.1016\/j.ucl.2024.02.005_bib70","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/nau.24900","article-title":"Is sacral neuromodulation effective in patients with Parkinson\u2019s disease? A retrospective review","volume":"41","author":"Martin","year":"2022","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.ucl.2024.02.005_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.sc.3100536","article-title":"Long-term suprapubic catheterisation: clinical outcome and satisfaction survey","volume":"36","author":"Sheriff","year":"1998","journal-title":"Spinal Cord"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014324000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014324000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T21:39:24Z","timestamp":1712785164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014324000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0094014324000119"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2024.02.005","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sleep and Overactive Bladder in Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}